David Bharucha
Directeur Technique/Scientifique/R&D chez MILESTONE PHARMACEUTICALS INC.
Fortune : 22 680 $ au 31/05/2024
Profil
David B.
Bharucha is currently the Chief Medical Officer at Milestone Pharmaceuticals, Inc. Prior to this, he worked as the VP-Clinical Development, Research & Development at Allergan Ltd.
(Ireland) from 2018 to 2021.
Dr. Bharucha received his undergraduate degree from Haverford College and his doctorate degree from The University of Chicago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2024 | 15 120 ( 0,03% ) | 22 680 $ | 31/05/2024 |
Postes actifs de David Bharucha
| Sociétés | Poste | Début |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 15/02/2022 |
Anciens postes connus de David Bharucha
| Sociétés | Poste | Fin |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | 01/01/2021 |
Formation de David Bharucha
| The University of Chicago | Doctorate Degree |
| Haverford College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
